Clinical Study for Atopic Dermatitis/Eczema – Teens and Adults
About the Study
Eczema is a general name that can cover a variety of usually very itchy disease processes. The more common are contact dermatitis (for example, poison oak) and atopic dermatitis. Atopic dermatitis affects about 15% of children in some countries, including the USA. Atopic dermatitis runs in families and usually begins before the age of five years, commonly during infancy. Fortunately, many people stop experiencing symptoms by early adulthood. People with atopic dermatitis may also have asthma or seasonal allergies, but atopic dermatitis is not caused by allergies.
Atopic dermatitis symptoms include dry skin and redness/inflammation, which creates very itchy skin. Scratching is common as a result of all the itching, which can cause raw areas, sometimes with oozing and crusting. Skin infections can be a result of this process.
In the very young, eczema is commonly found on the face, scalp, feet, and hands. In older children and adults it can move to the inside of the knees and elbows. Other common areas are the eyelids, neck, hands, and feet, although it can appear on any area of the body. Quality of life is significantly impacted for people with moderate-to-severe eczema.
Right now, dermatologists at Oregon Medical Research Center are accepting teen and adult participants for a new clinical research study. The study is for an investigational oral medication for moderate-to-severe atopic dermatitis.
If you or your child (ages 12 to 75) has moderate-to-severe atopic dermatitis, you may qualify for a new clinical research study evaluating the safety and efficacy of an investigational oral medication. Additional qualifications include: having atopic dermatitis for at least 6 months, weighing at least 88 pounds, and having had an inadequate response to topical medications.
By joining the study you or your child may receive:
- Evaluations of your atopic dermatitis by our dermatologists
- Study-related care and medication at no cost (you do not need insurance to participate, but you or your child will need to attend up to 21 scheduled visits at our office during an approximate 2.5 year period)
- Compensation for time and travel to attend study visits
What is the purpose of a clinical study?
Clinical research studies (also called clinical trials) are used to learn about the safety and the effectiveness of possible new medications. Although there are many types of clinical trials, all must conform to strict rules set by the U.S. Food and Drug Administration (FDA). These rules help protect the rights and the safety of those who volunteer to take part in clinical trials.
Will I have to pay for anything if I participate?
If you or your child qualify and choose to participate, you or your child will receive study-related care (such as study medications and visits to our office) at no cost. Compensation will also be provided for your time and travel to attend study visits.
How long does the study last?
If you or your child joins the study, participation will last up to approximately 2.5 years and require up to 21 scheduled visits to our office near Washington Square, at the Greenburg Road exit, just off Highway 217. These visits are an important part of the study, as they allow your study doctor to closely monitor your progress.
Does this study have a placebo?
Most clinical studies have a control group who do not receive medication during the study, or for a period of time during the study. This study has an inactive placebo (1 in 3 may receive the placebo), but at week 16 participants on placebo will be transitioned to the study medication.
What if I join the study and decide I do not want to participate anymore?
As with all clinical studies, participation is completely voluntary and you may choose to leave the study at any time.
I’m interested in hearing more. What is the next step?
To learn more about the study, give us a call at 503-245-1525, Monday through Thursday, during normal business hours, or Sign Up Today and we will give you a call to provide additional information.